Similar articles

• [Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].

  Ohfuji K, Yano S, Yamaguchi M, Smith G, Hirata M, Shimada H, Izuishi K, Shinagawa J, Matsunaga K. Ohfuji K, et al. Nihon Yakurigaku Zasshi. 2005 Sep;126(3):213-9. doi: 10.1254/fpj.126.213. Nihon Yakurigaku Zasshi. 2005. PMID: 16272766 Review. Japanese. No abstract available.
• [Rosuvastatin: pharmacologic features].

  Bernini F, Catapano AL. Bernini F, et al. Ital Heart J. 2003 Dec;4 Suppl 7:22S-32S. Ital Heart J. 2003. PMID: 14983744 Review. Italian.
• Pharmacodynamic interaction between ezetimibe and rosuvastatin.

  Kosoglou T, Statkevich P, Yang B, Suresh R, Zhu Y, Boutros T, Maxwell SE, Tiessen R, Cutler DL. Kosoglou T, et al. Curr Med Res Opin. 2004 Aug;20(8):1185-95. doi: 10.1185/030079904125004213. Curr Med Res Opin. 2004. PMID: 15324521 Clinical Trial.
• Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia.

  Avis HJ, Hargreaves IP, Ruiter JP, Land JM, Wanders RJ, Wijburg FA. Avis HJ, et al. J Pediatr. 2011 Mar;158(3):458-62. doi: 10.1016/j.jpeds.2010.08.015. J Pediatr. 2011. PMID: 20884007
• Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia.

  Pirro M, Schillaci G, Mannarino MR, Savarese G, Vaudo G, Siepi D, Paltriccia R, Mannarino E. Pirro M, et al. Nutr Metab Cardiovasc Dis. 2007 Jul;17(6):436-41. doi: 10.1016/j.numecd.2006.02.009. Epub 2006 Jul 7. Nutr Metab Cardiovasc Dis. 2007. PMID: 17134956 Clinical Trial.